Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review-Reference-Cited by-同舟云学术

Potential COVID‐19 Therapeutic Agents and Vaccines: An Evidence‐Based Review

Published:2021-03-05 Issue:4 Volume:61 Page:429-460
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Khani Elnaz¹,Khiali Sajad¹,Entezari‐Maleki Taher¹²^ORCID

Affiliation:

1. Department of Clinical Pharmacy Faculty of Pharmacy Tabriz University of Medical Sciences Tabriz Iran

2. Cardiovascular Research Center Tabriz University of Medical Sciences Tabriz Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.1822

Reference168 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) weekly epidemiological update.https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/20200824‐weekly‐epi‐update.pdf?sfvrsn=806986d1_4. Accessed August 24 2020.

2. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

3. World Health Organization.Novel Coronavirus (2019‐nCoV) Situation Report‐22.https://www.who.int/docs/default‐source/coronaviruse/situation‐reports/20200211‐sitrep‐22‐ncov.pdf?sfvrsn=fb6d49b1_2. Accessed April 9 2020.

4. Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome

5. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutics for COVID-19;Textbook of SARS-CoV-2 and COVID-19;2024

2. Medical technologies assessment in COVID-19;HIV Infection and Immunosuppressive Disorders;2023-10-21

3. Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq;Cellular and Molecular Biology;2023-03-31

4. The Role of Cyclodextrins in COVID-19 Therapy—A Literature Review;International Journal of Molecular Sciences;2023-02-03

5. Challenges in evaluating treatments for COVID-19: The case of in-hospital anticoagulant use and the risk of adverse outcomes;Frontiers in Pharmacology;2022-11-24